Merck Starts Tender Offer to Buy Terns Pharmaceuticals
Merck launches a tender offer to acquire Terns Pharmaceuticals, with plans to make it a wholly owned subsidiary.
US Securities And Exchange Commission (SEC) | 08/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy